arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Sintx Technologies, Inc.

SINT
$1.67 ▲ +0.05 (+3.09%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
14 Visible periods
30 Metrics
Absolute Benchmarks
Price Chart
25
Health
Poor
Bearish Absolute basis
auto_awesome

Analytical Summary

On an absolute basis, Sintx Technologies, Inc. shows weak fundamentals, weighed down by Return on Invested Capital and Interest Coverage. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.

Market Cap $4.6M
Dividend Yield
Revenue Growth -64.7%
Op. Margin None
ROIC -289.2%
FCF / Share $-3.16
Trailing P/E
Price / Book 2.3x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

14-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.02M
↓ -64.7%
Net Income Profit after all expenses
$-10.36M
↑ +6.0%
Operating Margin Operating profit as % of sales
-486.6%
↓ -394.2%
FCF / Share Free cash flow per share
$-3.16
↑ +74.9%
Long-Term Debt Long-term obligations
$368.00K
↑ +28.2%

info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.

trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Invested CapitalReturn on Invested Capital of -289.2% is weak on an absolute basis (target > 10%)
  • Interest CoverageInterest Coverage of -206.17x is weak on an absolute basis (target > 5x)
  • FCF / Net IncomeFCF / Net Income of 0.84x is caution on an absolute basis (target > 1x)

Health Breakdown

Financial Health
18
Cash Quality
38

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 14 years · 54 quarters